預測腫瘤學的大膽飛躍：人工智能，數字資產和國庫策略革命

預測腫瘤學（POAI）通過潛入數字資產，特別是Aethir（ATH）令牌，旨在促進AI驅動的藥物發現並建立戰略性計算儲備，從而震撼了生物技術。

Yo, what's up, Wall Street watchers! Predictive Oncology (POAI) is making waves, blending AI-driven cancer research with a bold digital asset treasury strategy. This ain't your grandma's biotech play.

喲，怎麼了，華爾街觀察家！預測腫瘤學（POAI）正在引起浪潮，將AI驅動的癌症研究與大膽的數字資產庫策略融為一體。這不是您奶奶的生物技術。

POAI's $344 Million Crypto Gamble: A Breakdown

POAI的3.44億美元加密賭博：故障

Predictive Oncology, a Pittsburgh-based company focused on using AI to accelerate cancer drug discovery, just priced two private placements totaling a cool $344 million. The kicker? They're diving headfirst into digital assets, with Aethir (ATH) tokens leading the charge.

一家總部位於匹茲堡的公司預測腫瘤學致力於使用AI加速癌症藥物發現，剛剛定價了兩個私人位置，總計3.44億美元。踢球？他們首先跳入數字資產，而Aethir（ATH）令牌領導了這一指控。

Here’s the deal:

這是交易：

• Cash Infusion: Roughly $52 million raised through stock sales.
• Crypto Swap: A hefty $293 million in Aethir tokens for pre-funded warrants.

The plan is simple: amass ATH tokens to fuel their AI computing needs and create a Strategic Compute Reserve. Aethir, for those not in the know, runs a decentralized GPU network, offering AI computing power at prices that undercut the big cloud providers.

該計劃很簡單：Amass Ath代幣可以促進​​其AI計算需求並創建戰略性計算儲備。對於那些不認識的人來說，Aethir運營著一個分散的GPU網絡，以削弱大雲提供商的價格提供AI計算能力。

Why Aethir? The GPU Gold Rush

為什麼是艾西爾？ GPU淘金熱

Aethir isn't just another crypto fad. It's a network providing crucial GPU resources for AI development. Predictive Oncology is betting that as AI demand skyrockets, so will the value of ATH tokens. Plus, POAI gets a 20% bonus in ATH tokens for every purchase they make, creating a virtuous cycle.

Aethir不僅是另一種加密時尚。這是一個為AI開發提供重要的GPU資源的網絡。預測性腫瘤學押注，隨著AI的需求Skyrockets，ATH令牌的價值也會如此。另外，Poai在他們進行的每次購買中都會在ATH令牌中獲得20％的獎勵，從而創造出良好的周期。

Strategic Compute Reserve: More Than Just Hype

戰略計算儲備：不僅僅是炒作

CEO Raymond Vennare calls this move a "seminal event," aiming to supercharge POAI's core business while tapping into AI's future. Aethir’s co-founder Dan Wang envisions a “world’s first Strategic Compute Reserve.” This isn't just about holding tokens; it's about powering the Aethir network and securing access to essential AI infrastructure.

首席執行官雷蒙德·維納爾（Raymond Vennare）稱這一舉動為“開創性事件”，旨在在利用AI的未來的同時增強POAI的核心業務。 Aethir的聯合創始人Dan Wang設想了“世界上第一個戰略計算儲備”。這不僅僅是持有令牌；這是關於為Aethir網絡提供動力並確保獲得基本AI基礎架構的訪問。

The Bigger Picture: Biotech Meets Blockchain

大局：生物技術遇到區塊鏈

AI is hungry for computing power, and companies that can bridge healthcare with cutting-edge tech are positioned for major wins. Predictive Oncology's AI platform already boasts a 92% accuracy in predicting drug response in tumors. Adding a crypto treasury is like strapping a rocket to a sports car, and could rewrite how medical breakthroughs are funded and fueled.

AI渴望計算能力，可以將醫療保健橋接的公司定位為重大勝利。預測腫瘤學的AI平台已經在預測腫瘤的藥物反應方面具有92％的精度。添加加密貨幣就像將火箭綁在跑車上，並且可以重寫醫療突破的資金和加油方式。

Potential and Pitfalls: A Reality Check

潛力和陷阱：現實檢查

Let's be real—there are risks. Crypto is volatile, ATH's value depends on Aethir's success, and issuing new shares dilutes existing holdings. But the potential rewards are significant. If Aethir takes off, POAI's ATH holdings could multiply, funding drug discovery without bleeding shareholders dry. Plus, they've got Wall Street heavyweights like H.C. Wainwright backing them.

讓我們成為現實 - 有風險。 Crypto是波動的，ATH的價值取決於Aethir的成功，並發行新股份稀釋了現有的持股。但是潛在的獎勵很大。如果Aethir起飛，Poai的Ath Holdings可能會繁殖，從而在不流血股東乾燥的情況下資助毒品。另外，他們還有華爾街重量級人物，例如HC Wainwright支持他們。

Final Thoughts: Eyes on the Future

最終想法：注視未來

Predictive Oncology's dive into digital assets is a bold move that could redefine the intersection of biotech and AI. It's a high-stakes game with potentially massive rewards. Keep your eyes peeled, folks, because this is one wild ride you don't want to miss!

預測腫瘤學進入數字資產是一個大膽的舉動，可以重新定義生物技術和AI的交集。這是一款高風險的遊戲，並具有巨大的回報。伙計們，請睜大眼睛，因為這是您不想錯過的一次狂野旅程！